S&P 500   3,870.29 (-0.81%)
DOW   31,391.52 (-0.46%)
QQQ   318.40 (-1.60%)
AAPL   125.12 (-2.09%)
MSFT   233.87 (-1.30%)
FB   259.00 (-2.23%)
GOOGL   2,064.48 (-0.25%)
TSLA   686.44 (-4.45%)
AMZN   3,094.53 (-1.64%)
NVDA   536.25 (-3.15%)
BABA   234.42 (-3.01%)
CGC   35.25 (+1.50%)
GE   12.98 (-0.99%)
MU   91.09 (-3.87%)
NIO   43.29 (-13.00%)
AMD   84.13 (-2.62%)
T   28.22 (+0.46%)
F   12.55 (+4.76%)
ACB   11.03 (-0.09%)
DIS   193.94 (-0.53%)
BA   223.14 (-0.56%)
NFLX   547.82 (-0.51%)
BAC   35.53 (-0.73%)
S&P 500   3,870.29 (-0.81%)
DOW   31,391.52 (-0.46%)
QQQ   318.40 (-1.60%)
AAPL   125.12 (-2.09%)
MSFT   233.87 (-1.30%)
FB   259.00 (-2.23%)
GOOGL   2,064.48 (-0.25%)
TSLA   686.44 (-4.45%)
AMZN   3,094.53 (-1.64%)
NVDA   536.25 (-3.15%)
BABA   234.42 (-3.01%)
CGC   35.25 (+1.50%)
GE   12.98 (-0.99%)
MU   91.09 (-3.87%)
NIO   43.29 (-13.00%)
AMD   84.13 (-2.62%)
T   28.22 (+0.46%)
F   12.55 (+4.76%)
ACB   11.03 (-0.09%)
DIS   193.94 (-0.53%)
BA   223.14 (-0.56%)
NFLX   547.82 (-0.51%)
BAC   35.53 (-0.73%)
S&P 500   3,870.29 (-0.81%)
DOW   31,391.52 (-0.46%)
QQQ   318.40 (-1.60%)
AAPL   125.12 (-2.09%)
MSFT   233.87 (-1.30%)
FB   259.00 (-2.23%)
GOOGL   2,064.48 (-0.25%)
TSLA   686.44 (-4.45%)
AMZN   3,094.53 (-1.64%)
NVDA   536.25 (-3.15%)
BABA   234.42 (-3.01%)
CGC   35.25 (+1.50%)
GE   12.98 (-0.99%)
MU   91.09 (-3.87%)
NIO   43.29 (-13.00%)
AMD   84.13 (-2.62%)
T   28.22 (+0.46%)
F   12.55 (+4.76%)
ACB   11.03 (-0.09%)
DIS   193.94 (-0.53%)
BA   223.14 (-0.56%)
NFLX   547.82 (-0.51%)
BAC   35.53 (-0.73%)
S&P 500   3,870.29 (-0.81%)
DOW   31,391.52 (-0.46%)
QQQ   318.40 (-1.60%)
AAPL   125.12 (-2.09%)
MSFT   233.87 (-1.30%)
FB   259.00 (-2.23%)
GOOGL   2,064.48 (-0.25%)
TSLA   686.44 (-4.45%)
AMZN   3,094.53 (-1.64%)
NVDA   536.25 (-3.15%)
BABA   234.42 (-3.01%)
CGC   35.25 (+1.50%)
GE   12.98 (-0.99%)
MU   91.09 (-3.87%)
NIO   43.29 (-13.00%)
AMD   84.13 (-2.62%)
T   28.22 (+0.46%)
F   12.55 (+4.76%)
ACB   11.03 (-0.09%)
DIS   193.94 (-0.53%)
BA   223.14 (-0.56%)
NFLX   547.82 (-0.51%)
BAC   35.53 (-0.73%)
Log in
NASDAQ:STOK

Stoke Therapeutics Short Interest Ratio and Short Volume

$60.00
-1.14 (-1.86 %)
(As of 03/2/2021 04:30 PM ET)
Add
Compare
Today's Range
$59.25
Now: $60.00
$64.14
50-Day Range
$58.20
MA: $62.41
$69.81
52-Week Range
$15.82
Now: $60.00
$71.58
Volume273,216 shs
Average Volume131,510 shs
Market Capitalization$2.01 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.63

Short Interest

Stoke Therapeutics (NASDAQ:STOK) Short Interest Data

Current Short Volume3,370,000 shares
Previous Short Volume3,480,000 shares
Change Vs. Previous Month:-3.16%
Dollar Volume Sold Short$201.83 million
Short Interest Ratio / Days to Cover21.1
Last Record DateFebruary, 12 2021
Outstanding Shares31,460,000 shares
Float Size18,820,000 shares
Short Percent of Float17.91%
Today's Trading Volume273,216 shares
Average Trading Volume131,510 shares
Today's Volume Vs. Average107.75%

Short Interest Over Time


Stoke Therapeutics (NASDAQ:STOK) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
2/12/20213,370,000 shares $201.83 million -3.2%17.9%21.1 $59.89
1/29/20213,480,000 shares $217.40 million +0.9%18.8%21.4 $62.47
1/15/20213,450,000 shares $213.93 million -2.8%18.6%21.6 $62.01
12/31/20202,970,000 shares $173.51 million +0.7%16.3%21.8 $58.42
12/15/20202,970,000 shares $169.71 million +0.7%16.3%21.8 $57.14
11/30/20202,950,000 shares $178.68 million +3.9%16.2%24.5 $60.57
11/15/20202,840,000 shares $147.94 million -0.7%16.5%24.9 $52.09
10/30/20202,860,000 shares $128.67 million -1.0%18.1%33.1 $44.99
10/15/20202,890,000 shares $118.55 million +1.8%18.3%33.1 $41.02
9/30/20202,840,000 shares $110.90 million +1.4%18.0%27.3 $39.05
9/15/20202,800,000 shares $96.71 million +1.1%17.7%23.6 $34.54
8/31/20202,770,000 shares $89.66 million +3.4%17.5%21.5 $32.37
8/14/20202,680,000 shares $76.54 million +3.9%17.0%20 $28.56
7/31/20202,580,000 shares $74.33 million +3.2%16.5%18.5 $28.81
7/15/20202,500,000 shares $62.98 million -29.6%16.0%18.5 $25.19
6/30/20203,550,000 shares $89.28 million +13.4%22.9%25.2 $25.15
6/15/20203,130,000 shares $72.62 million +2.6%20.2%20.6 $23.20
5/29/20203,050,000 shares $72.35 million +0.7%19.7%16.3 $23.72
5/15/20203,030,000 shares $83.81 million +2.0%19.3%15.2 $27.66
4/30/20202,970,000 shares $82.54 million +2.1%18.9%14.1 $27.79
4/15/20202,910,000 shares $68.71 million +6.2%18.6%12.5 $23.61
3/31/20202,740,000 shares $62.31 million -0.1%17.4%12.1 $22.74
3/13/20202,743,000 shares $59.66 million +10.2%N/A10.5 $21.75
2/28/20202,490,000 shares $48.85 million +6.4%N/A14.3 $19.62
2/14/20202,340,000 shares $55.79 million +13.0%15.1%14.7 $23.84

Stoke Therapeutics (NASDAQ:STOK) Short Interest FAQ

speech bubbles
speech bubbles











What is Stoke Therapeutics' current short interest?

Short interest is the volume of Stoke Therapeutics shares that have been sold short but have not yet been closed out or covered. As of February 12th, investors have sold 3,370,000 shares of STOK short. 17.91% of Stoke Therapeutics' shares are currently sold short. View details.

What is a good short interest ratio for Stoke Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. Stoke Therapeutics currently has a short interest ratio of 21.0.

What is a good short interest percentage for Stoke Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 17.91% of Stoke Therapeutics' floating shares are currently sold short.

Is Stoke Therapeutics' short interest increasing or decreasing?

Stoke Therapeutics saw a drop in short interest in the month of February. As of February 12th, there was short interest totaling 3,370,000 shares, a drop of 3.2% from the previous total of 3,480,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Stoke Therapeutics' float size?

Stoke Therapeutics currently has issued a total of 33,470,000 shares. Some of Stoke Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Stoke Therapeutics currently has a public float of 18,820,000 shares.

How does Stoke Therapeutics' short interest compare to its competitors?

17.91% of Stoke Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Stoke Therapeutics: Ionis Pharmaceuticals, Inc. (5.97%), ACADIA Pharmaceuticals Inc. (0.00%), United Therapeutics Co. (4.02%), Schrödinger, Inc. (6.47%), Sarepta Therapeutics, Inc. (0.00%), GW Pharmaceuticals plc (0.00%), Evotec SE (0.00%), Allakos Inc. (9.06%), Atea Pharmaceuticals, Inc. (3.65%), and Maravai LifeSciences Holdings, Inc. (3.64%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: ViacomCBS Inc. ($6.50 billion), Aon Plc ($5.58 billion), Charter Communications, Inc. ($5.30 billion), Analog Devices, Inc. ($4.97 billion), Snap Inc. ($3.80 billion), Futu Holdings Limited ($2.84 billion), Airbnb, Inc. ($2.40 billion), Discovery, Inc. ($2.35 billion), Snowflake Inc. ($2.07 billion), and The Kroger Co. ($2.00 billion). View all of the most shorted stocks.

What does it mean to sell short Stoke Therapeutics stock?

Short selling STOK is an investing strategy that aims to generate trading profit from Stoke Therapeutics as its price is falling. Stoke Therapeutics' stock is trading down $1.14 today. To short Stoke Therapeutics stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Stoke Therapeutics will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Stoke Therapeutics?

A short squeeze for Stoke Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of STOK, which in turn drives the price of the stock up even further.

How often is Stoke Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including STOK, twice per month. The most recent reporting period available is February, 12 2021.



This page was last updated on 3/2/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.